次世代シーケンシング（NGS）サービス市場：タイプ別（ターゲットシーケンシング、Exome、RNA-Seq、ChIPシーケンシング）、技術別（合成シーケンシング、ナノポア、SMRT）、用途別（臨床診断、バイオマーカー探索）、エンドユーザー別-2028年までの予測

世界の次世代シーケンシング（NGS）サービスの市場規模は、2021年から2028年にかけて20.4%のCAGRで成長し、2028年には141億米ドルに達すると予測されています。同市場成長の主な要因には、NGS手法のコスト削減、新しい標的療法の開発と承認、がんの有病率の上昇、NGSサービスプロバイダーと製薬企業の提携、シーケンシングインフラの高コスト化、NGSの技術的進歩などが挙げられます。また、シーケンシングデータ解析の進歩や、がんやアグリゲノミクス研究におけるNGSの応用の増加は、NGSサービスプロバイダに大きな成長機会をもたらすと予想されます。

ただし、代替技術の利用可能性、サンプルの準備と分析のための熟練した専門家の不足、精密医療のための実用的な変異などが、同市場の成長を抑制する可能性があり、さらに、診断検査における規制・標準化への懸念、非侵襲的出生前遺伝学的検査に関連する倫理的問題やコストが、同市場成長にとって大きな課題となっています。

当レポートは、世界の次世代シーケンシング（NGS）サービス市場について調査しており、市場規模や予測、成長および抑制要因、機会や課題、タイプ・用途・技術・エンドユーザー・地域別の市場分析、競合情勢、主要企業のプロファイルなどの情報を提供しています。

目次

第1章 イントロダクション

• 市場の定義
• 市場エコシステム
• 通貨
• 主要ステークホルダー

第2章 調査手法

• 調査プロセス
• データ収集と検証
  • 2次調査
  • 1次調査
• 市場評価
  • 市場規模推計
  • 市場シェア分析
• 当調査の前提条件
• 調査の限界

第3章 エグゼクティブサマリー

第4章 市場の洞察

• 市場概要
• 成長要因
  • シーケンシング手法のコスト急落
  • 新しい標的療法の開発と承認
  • がんの有病率の上昇
  • NGSサービスプロバイダーと製薬企業間のパートナーシップ
  • シーケンシングインフラストラクチャの高コスト
  • NGSの技術的進歩
• 抑制要因
  • 代替技術の利用可能性
  • サンプル調製と分析のための熟練した専門家の不足
  • 精密医療のためのポジティブな実行可能な突然変異の可能性が低い
• 市場機会
  • がんおよび農業ゲノミクス調査における用途の増加
  • シーケンシングデータ分析の進歩
• 課題
  • 診断検査における規制と標準化の懸念
  • 大病院や研究への社内NGS施設の設置
  • 非侵襲的な出生前遺伝子検査に関連する倫理的問題と費用
• Covid-19が世界のNGSサービス市場に与える影響

第5章 タイプ別：世界の次世代シーケンシング（NGS）サービス市場

• イントロダクション
• ターゲットシーケンシングサービス
• RNAシーケンシングサービス
• デノボシーケンシングサービス
• エクソームシーケンシングサービス
• チップシーケンシングサービス
• メチルシーケンシングサービス
• 全ゲノムシーケンシングサービス
• その他

第6章 技術別：世界の次世代シーケンシング（NGS）サービス市場

• イントロダクション
• 合成別シーケンシング（SBS）
• イオンセミコンダクターシーケンシング（IOS）
• 単一分子リアルタイム（SMRT）シーケンシング
• ナノポアシーケンシング
• その他

第7章 用途別：世界の次世代シーケンシング（NGS）サービス市場

• イントロダクション
• 診断
• 創薬
• バイオマーカーの発見
• 農業および動物研究
• その他の用途

第8章 エンドユーザー別：世界の次世代シーケンシング（NGS）サービス市場

• イントロダクション
• 病院とクリニック
• 製薬およびバイオテクノロジー企業
• 学術・研究機関
• その他のエンドユーザー

第9章 地域別：世界の次世代シーケンシング（NGS）サービス市場

• イントロダクション
• 北米
  • 米国
  • カナダ
• 欧州
  • ドイツ
  • フランス
  • 英国
  • イタリア
  • スペイン
  • その他欧州（RoE）
• アジア太平洋
  • 日本
  • 中国
  • インド
  • その他アジア太平洋（RoAPAC）
• ラテンアメリカ
• 中東とアフリカ

第10章 競合情勢

• イントロダクション
• 主要成長戦略
• 競合ベンチマーキング
• 市場シェア分析（2020）
  • Eurofins Scientific S.E.
  • Illumina, Inc.
  • Perkinelmer, Inc.
  • GENEWIZ, Inc.
  • Foundation Medicine, Inc.（F. Hoffmann-La Roche AG傘下）

第11章 企業プロファイル

• Illumina, Inc.
  • 事業の概要
  • 財務概要
  • サービスポートフォリオ
  • 戦略的開発
• QIAGEN N.V.
• PerkinElmer, Inc.
• Eurofins Scientific S.E.
• Macrogen, Inc.
• LGC Limited
• GENEWIZ, Inc.
• Beijing Genomics Institute (BGI)
• Scigenom Labs Pvt., Ltd.
• Medgenome Inc.
• DNA Link, Inc.
• Otogenetics Corporation
• Novogene Co., Ltd.
• CD Genomics
• SeqLL Inc.
• Foundation Medicine, Inc.（F. Hoffmann-La Roche AG傘下）

第12章 付録

• アンケート
• 利用可能なカスタマイズ

List of Tables

• Table 1 NGS Services Market Drivers: Impact Analysis (2021-2028)
• Table 2 Currently Available Targeted Therapies and Corresponding Biomarkers
• Table 3 Estimated Number of New Cancer Cases, by Type (2020)
• Table 4 NGS Services Market Restraints: Impact Analysis (2021-2028)
• Table 5 Global NGS Services Market Size, by Type, 2019-2028 (USD Million)
• Table 6 Global Targeted Sequencing Services Market Size, by Country/Region, 2019-2028 (USD Million)
• Table 7 Global RNA Sequencing Services Market Size, by Country/Region, 2019-2028 (USD Million)
• Table 8 Global De Novo Sequencing Services Market Size, by Country/Region, 2019-2028 (USD Million)
• Table 9 Global Exome Sequencing Services Market Size, by Country/Region, 2019-2028 (USD Million)
• Table 10 Global Chip Sequencing Services Market Size, by Country/Region, 2019-2028 (USD Million)
• Table 11 Global Methyl Sequencing Services Market Size, by Country/Region, 2019-2028 (USD Million)
• Table 12 Global Whole-Genome Sequencing Services Market Size, by Country/Region, 2019-2028 (USD Million)
• Table 13 Global Other NGS Services Market Size, by Country/Region, 2019-2028 (USD Million)
• Table 14 Global NGS Services Market Size, by Technology, 2019-2028 (USD Million)
• Table 15 Global Sbs-based NGS Services Market Size, by Country/Region, 2019-2028 (USD Million)
• Table 16 Global Ios-based NGS Services Market Size, by Country/Region, 2019-2028 (USD Million)
• Table 17 Global Smart Technology-based NGS Services Market Size, by Country/Region, 2019-2028 (USD Million)
• Table 18 Global Nanopore Technology-based NGS Services Market Size, by Country/Region, 2019-2028 (USD Million)
• Table 19 Global Other Technologies-based NGS Services Market Size, by Country/Region, 2019-2028 (USD Million)
• Table 20 Global NGS Services Market Size, by Application, 2019-2028 (USD Million)
• Table 21 Global NGS Services Market Size for Diagnostics, by Country/Region, 2019-2028 (USD Million)
• Table 22 Global NGS Services Market Size for Drug Discovery, by Country/Region, 2019-2028 (USD Million)
• Table 23 Tumor Markers in Different Cancer Types
• Table 24 Global NGS Services Market Size for Biomarker Discovery, by Country/Region, 2019-2028 (USD Million)
• Table 25 Global NGS Services Market Size for Agriculture & Animal Research, by Country/Region, 2019-2028 (USD Million)
• Table 26 Global NGS Services Market Size for Other Applications, by Country/Region, 2019-2028 (USD Million)
• Table 27 Global NGS Services Market Size, by End User, 2019-2028 (USD Million)
• Table 28 Global NGS Services Market Size for Hospitals & Clinics, by Country/Region, 2019-2028 (USD Million)
• Table 29 Global NGS Services Market Size for Pharmaceutical & Biotechnology Companies, by Country/Region, 2019-2028 (USD Million)
• Table 30 Global NGS Services Market Size for Academic & Research Institutes, by Country/Region, 2019-2028 (USD Million)
• Table 31 Global NGS Services Market Size for Other End Users, by Country/Region, 2019-2028 (USD Million)
• Table 32 Global NGS Services Market Size, by Country/Region, 2019-2028 (USD Million)
• Table 33 North America: NGS Services Market Size, by Country, 2019-2028 (USD Million)
• Table 34 North America: NGS Services Market Size, by Type, 2019-2028 (USD Million)
• Table 35 North America: NGS Services Market Size, by Technology, 2019-2028 (USD Million)
• Table 36 North America: NGS Services Market Size, by Application, 2019-2028 (USD Million)
• Table 37 North America: NGS Services Market Size, by End User, 2019-2028 (USD Million)
• Table 38 U.S.: Key Macroindicators
• Table 39 U.S.: NGS Services Market Size, by Type, 2019-2028 (USD Million)
• Table 40 U.S.: NGS Services Market Size, by Technology, 2019-2028 (USD Million)
• Table 41 U.S.: NGS Services Market Size, by Application, 2019-2028 (USD Million)
• Table 42 U.S.: NGS Services Market Size, by End User, 2019-2028 (USD Million)
• Table 43 Canada: Key Macroindicators
• Table 44 Canada: NGS Services Market Size, by Type, 2019-2028 (USD Million)
• Table 45 Canada: NGS Services Market Size, by Technology, 2019-2028 (USD Million)
• Table 46 Canada: NGS Services Market Size, by Application, 2019-2028 (USD Million)
• Table 47 Canada: NGS Services Market Size, by End User, 2019-2028 (USD Million)
• Table 48 Europe: NGS Services Market Size, by Country/Region, 2019-2028 (USD Million)
• Table 49 Europe: NGS Services Market Size, by Type, 2019-2028 (USD Million)
• Table 50 Europe: NGS Services Market Size, by Technology, 2019-2028 (USD Million)
• Table 51 Europe: NGS Services Market Size, by Application, 2019-2028 (USD Million)
• Table 52 Europe: NGS Services Market Size, by End User, 2019-2028 (USD Million)
• Table 53 Germany: Key Macroindicators
• Table 54 Germany: NGS Services Market Size, by Type, 2019-2028 (USD Million)
• Table 55 Germany: NGS Services Market Size, by Technology, 2019-2028 (USD Million)
• Table 56 Germany: NGS Services Market Size, by Application, 2019-2028 (USD Million)
• Table 57 Germany: NGS Services Market Size, by End User, 2019-2028 (USD Million)
• Table 58 France: Key Macroindicators
• Table 59 France: NGS Services Market Size, by Type, 2019-2028 (USD Million)
• Table 60 France: NGS Services Market Size, by Technology, 2019-2028 (USD Million)
• Table 61 France: NGS Services Market Size, by Application, 2019-2028 (USD Million)
• Table 62 France: NGS Services Market Size, by End User, 2019-2028 (USD Million)
• Table 63 U.K.: Key Macroindicators
• Table 64 U.K.: NGS Services Market Size, by Type, 2019-2028 (USD Million)
• Table 65 U.K.: NGS Services Market Size, by Technology, 2019-2028 (USD Million)
• Table 66 U.K.: NGS Services Market Size, by Application, 2019-2028 (USD Million)
• Table 67 U.K.: NGS Services Market Size, by End User, 2019-2028 (USD Million)
• Table 68 Italy: Key Macroindicators
• Table 69 U.K.: NGS Services Market Size, by Type, 2019-2028 (USD Million)
• Table 70 Italy: NGS Services Market Size, by Technology, 2019-2028 (USD Million)
• Table 71 Italy: NGS Services Market Size, by Application, 2019-2028 (USD Million)
• Table 72 Italy: NGS Services Market Size, by End User, 2019-2028 (USD Million)
• Table 73 Spain: Key Macroindicators
• Table 74 Spain: NGS Services Market Size, by Type, 2019-2028 (USD Million)
• Table 75 Spain: NGS Services Market Size, by Technology, 2019-2028 (USD Million)
• Table 76 Spain: NGS Services Market Size, by Application, 2019-2028 (USD Million)
• Table 77 Spain: NGS Services Market Size, by End User, 2019-2028 (USD Million)
• Table 78 Estimated Number of New Cancer Cases From 2020 To 2030
• Table 79 Roe: NGS Services Market Size, by Type, 2019-2028 (USD Million)
• Table 80 Roe: NGS Services Market Size, by Technology, 2019-2028 (USD Million)
• Table 81 Roe: NGS Services Market Size, by Application, 2019-2028 (USD Million)
• Table 82 Roe: NGS Services Market Size, by End User, 2019-2028 (USD Million)
• Table 83 Asia-Pacific: NGS Services Market Size, by Country/Region, 2019-2028 (USD Million)
• Table 84 Asia-Pacific: NGS Services Market Size, by Type, 2019-2028 (USD Million)
• Table 85 Asia-Pacific: NGS Services Market Size, by Technology, 2019-2028 (USD Million)
• Table 86 Asia-Pacific: NGS Services Market Size, by Application, 2019-2028 (USD Million)
• Table 87 Asia-Pacific: NGS Services Market Size, by End User, 2019-2028 (USD Million)
• Table 88 Japan: Key Macroindicators
• Table 89 Japan: NGS Services Market Size, by Type, 2019-2028 (USD Million)
• Table 90 Japan: NGS Services Market Size, by Technology, 2019-2028 (USD Million)
• Table 91 Japan: NGS Services Market Size, by Application, 2019-2028 (USD Million)
• Table 92 Japan: NGS Services Market Size, by End User, 2019-2028 (USD Million)
• Table 93 China: Key Macroindicators
• Table 94 China: NGS Services Market Size, by Type, 2019-2028 (USD Million)
• Table 95 China: NGS Services Market Size, by Technology, 2019-2028 (USD Million)
• Table 96 China: NGS Services Market Size, by Application, 2019-2028 (USD Million)
• Table 97 China: NGS Services Market Size, by End User, 2019-2028 (USD Million)
• Table 98 India: Key Macroindicators
• Table 99 India: NGS Services Market Size, by Type, 2019-2028 (USD Million)
• Table 100 India: NGS Services Market Size, by Technology, 2019-2028 (USD Million)
• Table 101 India: NGS Services Market Size, by Application, 2019-2028 (USD Million)
• Table 102 India: NGS Services Market Size, by End User, 2019-2028 (USD Million)
• Table 103 Estimated Number of New Cancer Cases From 2020 To 2030
• Table 104 Roapac: NGS Services Market Size, by Type, 2019-2028 (USD Million)
• Table 105 Roapac: NGS Services Market Size, by Technology, 2019-2028 (USD Million)
• Table 106 Roapac: NGS Services Market Size, by Application, 2019-2028 (USD Million)
• Table 107 Roapac: NGS Services Market Size, by End User, 2019-2028 (USD Million)
• Table 108 Latin America: NGS Services Market Size, by Type, 2019-2028 (USD Million)
• Table 109 Latin America: NGS Services Market Size, by Technology, 2019-2028 (USD Million)
• Table 110 Latin America: NGS Services Market Size, by Application, 2019-2028 (USD Million)
• Table 111 Latin America: NGS Services Market Size, by End User, 2019-2028 (USD Million)
• Table 112 Middle East & Africa: NGS Services Market Size, by Type, 2019-2028 (USD Million)
• Table 113 Middle East & Africa: NGS Services Market Size, by Technology, 2019-2028 (USD Million)
• Table 114 Middle East & Africa: NGS Services Market Size, by Application, 2019-2028 (USD Million)
• Table 115 Middle East & Africa: NGS Services Market Size, by End User, 2019-2028 (USD Million)
• Table 116 Recent Developments, by Company, 2018-2021

List of Figures

• Figure 1 Research Process
• Figure 2 Key Secondary Sources
• Figure 3 Primary Research Techniques
• Figure 4 Key Executives Interviewed
• Figure 5 Breakdown of Primary Interviews (Supply-Side & Demand-Side)
• Figure 6 Market Size Estimation
• Figure 7 Global Next-generation Sequencing Services Market Size, by Application, 2021 Vs. 2028 (USD Million)
• Figure 8 Global Next-generation Sequencing Services Market Size, by Type, 2021 Vs. 2028 (USD Million)
• Figure 9 Global Next-generation Sequencing Services Market Size, by Technology, 2021 Vs. 2028 (USD Million)
• Figure 10 Global Next-generation Sequencing Services Market Size, by End User, 2021 Vs. 2028 (USD Million)
• Figure 11 Next-generation Sequencing Services Market, by Geography
• Figure 12 Market Dynamics
• Figure 13 Cost of Genome Sequencing: 2010-2020
• Figure 14 Global NGS Services Market Size, by Type, 2021-2028 (USD Million)
• Figure 15 Number of Manuscripts Featuring RNA Sequencing Per Year on Pubmed
• Figure 16 Global NGS Services Market Size, by Technology, 2021-2028 (USD Million)
• Figure 17 Global NGS Services Market Size, by Application, 2021-2028 (USD Million)
• Figure 18 New Molecular Entity (NME) Approvals Per Year
• Figure 19 Global NGS Services Market Size, by End User, 2021-2028 (USD Million)
• Figure 20 Global Biopharmaceutical R&D Spending, 2014-2020 (USD Billion)
• Figure 21 Global NGS Services Market Size, by Geography, 2021-2028 (USD Million)
• Figure 22 North America: NGS Services Market Snapshot
• Figure 23 Pharmaceutical R&D Expenditure in the U.S.
• Figure 24 Pharmaceutical Industry Research and Development in Europe (2019)
• Figure 25 Europe: NGS Services Market Snapshot
• Figure 26 Number of Biotechnology Firms in Italy, 2008-2019
• Figure 27 R&D Spending by Pharmaceutical Industry in Spain, 2015-2019 (USD Million)
• Figure 28 Pharmaceutical R&D Spending in Roe (2019)
• Figure 29 Asia-Pacific: NGS Services Market Snapshot
• Figure 30 Key Growth Strategies Adopted by Leading Players, 2018-2021
• Figure 31 NGS Services: Competitive Benchmarking (Based on Service Type)
• Figure 32 NGS Services: Competitive Benchmarking (Based on Geography)
• Figure 33 Market Share Analysis: NGS Services Industry, 2020
• Figure 34 Illumina, Inc.: Financial Overview, 2020
• Figure 35 Qiagen N.V.: Financial Overview, 2020
• Figure 36 Perkinelmer, Inc.: Financial Overview, 2020
• Figure 37 Eurofins Scientific S.E.: Financial Overview, 2020
• Figure 38 Macrogen, Inc.: Financial Overview, 2020
• Figure 39 LGC Limited: Financial Overview, 2020
• Figure 40 Brooks Automation, Inc.: Financial Overview, 2020
• Figure 41 SeqLL Inc.: Financial Overview, 2020
• Figure 42 F. Hoffmann-La Roche AG.: Financial Overview, 2020

Global Next-generation Sequencing Services Market by Type (Targeted Sequencing, Exome, RNA-Seq, ChIP Sequencing), Technology (Sequencing by Synthesis, Nanopore, SMRT), Application (Clinical Diagnosis, Biomarker Discovery), and End User - Forecast to 2028

The next-generation sequencing services market is expected to grow at a CAGR of 20.4% from 2021 to 2028 to reach $14.1 billion by 2028.

Following a thorough secondary and primary research and in-depth analysis of the market scenario, the report discusses key industry drivers, restraints, challenges, and opportunities.

The growth of this market is mainly attributed to the reducing cost of NGS procedures, the development and approval of new targeted therapies, rising prevalence of cancer, partnerships between NGS service providers and pharmaceutical companies, high cost of sequencing infrastructure, and technological advancements in NGS. In addition, advancements in sequencing data analytics and the increasing applications of NGS in cancer and agri-genomics research are expected to offer significant growth opportunities for NGS service providers.

However, the availability of alternative technologies, lack of skilled professionals for sample preparation and analysis, and actionable mutations for precision medicine may restrain the growth of the NGS services market. Moreover, regulatory & standardization concerns in diagnostic testing and the ethical issues & costs related to non-invasive prenatal genetic testing are major challenges for the growth of this market.

Based on type, the global NGS services market is segmented into targeted sequencing services, whole-genome sequencing services, RNA sequencing services, exome sequencing services, de novo sequencing services, ChIP sequencing services, methyl sequencing services, and other NGS services. In 2021, the targeted sequencing services segment is estimated to account for the largest share of the global NGS services market. The large share of this segment can be attributed to the relatively lower cost, faster turnaround time, and accurate, easy-to-interpret results of targeted sequencing in the study of disease-related genes.

Based on technology, the global NGS services market is segmented into sequencing by synthesis (SBS), ion semiconductor sequencing (IOS), single-molecule real-time sequencing (SMRT), nanopore sequencing, and other NGS technologies. In 2021, the sequencing by synthesis (SBS) segment is estimated to account for the largest share of the global NGS services market. This large share of this segment is attributed to its highest yield of error-free throughput, base call value above Q30, and higher accuracy in DNA sequencing compared to other sequencing technologies available in the market.

Based on application, the global NGS services market is segmented into biomarker discovery, diagnostics, drug discovery, agriculture & animal research, and other applications. In 2021, the diagnostics segment is estimated to account for the largest share of the global NGS services market. This segment's large share is mainly attributed to the significant use of NGS services in cancer diagnostics globally and improvements in NGS-based oncology and non-invasive prenatal tests (NIPT). Growing emphasis on utilizing NGS in cancer research fuels the growth of this market.

Based on end user, the global NGS services market is segmented into hospitals & clinics, pharmaceutical & biotechnology companies, academic & research institutes, and other end users. In 2021, the hospitals & clinics segment is estimated to account for the largest share of the global NGS services market. The largest share of this segment is attributed to factors such as high capital requirements for building in-house NGS capabilities in hospitals & clinics, the rising prevalence of cancer and other chronic diseases, the growing demand for advanced medical treatments, and the rising number of biomarker-based therapies.

An in-depth analysis of the geographical scenario of the next-generation sequencing services market provides detailed qualitative and quantitative insights about the five major geographies (North America, Europe, Asia-Pacific, Latin America, and the Middle East & Africa) along with the coverage of major countries in each region. North America is expected to command the largest share of the global next-generation sequencing services market in 2021, followed by Europe and Asia-Pacific.

Key companies operating in the global next-generation sequencing services market are Illumina, Inc. (U.S.), QIAGEN N.V. (Netherland), PerkinElmer, Inc. (U.S.), Eurofins Scientific S.E. (Luxembourg), Macrogen, Inc. (South Korea), LGC Limited (U.K.), GENEWIZ, Inc. (U.S.), Beijing Genomics Institute (BGI) (China), SciGenom Labs Pvt. Ltd (India), MedGenome Inc. (U.S.), DNA Link, Inc. (South Korea), Otogenetics Corporation (U.S.), Novogene Co., Ltd. (China), CD Genomics (U.S.), Foundation Medicine, Inc. (U.S), and SeqLL, Inc. (U.S.).

Scope of the Report

Global Next-generation Sequencing Services Market, by Type

• Targeted Sequencing Services
• RNA Sequencing Services
• De Novo Sequencing Services
• Exome Sequencing Services
• Chip Sequencing Services
• Whole-genome Sequencing
• Methyl Sequencing Services
• Other Services

Global Next-generation Sequencing Services Market, by Technology

• Sequencing By Synthesis (SBS)
• Ion Semiconductor Sequencing (IOS)
• Single-molecule Real-time Sequencing (SMRT)
• Nanopore Sequencing
• Other Technologies

Global Next-generation Sequencing Services Market, by Application

• Diagnostics
• Drug Discovery
• Biomarker Discovery
• Agriculture & Animal Research
• Other Applications

Global Next-generation Sequencing Services Market, by End User

• Hospitals & Clinics
• Pharmaceutical & Biotechnology Companies
• Academics & Research Institutes
• Other End Users

Global Next-generation Sequencing Services Market, by Geography

• North America
  • U.S.
  • Canada
• Europe
  • Germany
  • France
  • U.K.
  • Italy
  • Spain
  • Rest of Europe (RoE)
• Asia-Pacific (APAC)
  • Japan
  • China
  • India
  • Rest of APAC (RoAPAC)
• Latin America
• Middle East & Africa

TABLE OF CONTENTS

1. Introduction

• 1.1. Market Definition
• 1.2. Market Ecosystem
• 1.3. Currency
• 1.4. Key Stakeholders

2. Research Methodology

• 2.1. Research Process
• 2.2. Data Collection & Validation
  • 2.2.1. Secondary Research
  • 2.2.2. Primary Research
• 2.3. Market Assessment
  • 2.3.1. Market Size Estimation
    • 2.3.1.1. Bottom-Up Approach
    • 2.3.1.2. Top-Down Approach
    • 2.3.1.3. Growth Forecast
  • 2.3.2. Market Share Analysis
• 2.4. Assumptions for This Study
• 2.5. Limitations for The Study

3. Executive Summary

4. Market Insights

• 4.1. Market Overview
• 4.2. Drivers
  • 4.2.1. Plummeting Costs of Sequencing Procedures
  • 4.2.2. Development and Approval of New Targeted Therapies
  • 4.2.3. Rising Prevalence of Cancer
  • 4.2.4. Partnerships Between NGS Service Providers and Pharmaceutical Companies
  • 4.2.5. High Cost of Sequencing Infrastructure
  • 4.2.6. Technological Advancements in NGS
• 4.3. Restraints
  • 4.3.1. Availability of Alternative Technologies
  • 4.3.2. Lack of Skilled Professionals for Sample Preparation and Analysis
  • 4.3.3. Low Chances of Positive Actionable Mutations for Precision Medicine
• 4.4. Opportunities
  • 4.4.1. Increasing Applications in Cancer and Agri-Genomics Research
  • 4.4.2. Advancements in Sequencing Data Analytics
• 4.5. Challenges
  • 4.5.1. Regulatory & Standardization Concerns in Diagnostic Testing
  • 4.5.2. Installation of In-House NGS Facilities in Large Hospitals and Research Institutes
  • 4.5.3. Ethical Issues & Costs Related to Non-Invasive Prenatal Genetic Testing
• 4.6. The Impact of Covid-19 on The Global NGS Services Market

5. Global Next-Generation Sequencing Services Market, by Type

• 5.1. Introduction
• 5.2. Targeted Sequencing Services
• 5.3. RNA Sequencing Services
• 5.4. De Novo Sequencing Services
• 5.5. Exome Sequencing Services
• 5.6. Chip Sequencing Services
• 5.7. Methyl Sequencing Services
• 5.8. Whole-Genome Sequencing Services
• 5.9. Other NGS Services

6. Global Next-Generation Sequencing Services Market, by Technology

• 6.1. Introduction
• 6.2. Sequencing by Synthesis (SBS)
• 6.3. Ion Semiconductor Sequencing (IOS)
• 6.4. Single-Molecule Real-Time (SMRT) Sequencing
• 6.5. Nanopore Sequencing
• 6.6. Other NGS Technologies

7. Global Next-Generation Sequencing Services Market, by Application

• 7.1. Introduction
• 7.2. Diagnostics
• 7.3. Drug Discovery
• 7.4. Biomarker Discovery
• 7.5. Agriculture & Animal Research
• 7.6. Other Applications

8. Global Next-Generation Sequencing Services Market, by End User

• 8.1. Introduction
• 8.2. Hospitals & Clinics
• 8.3. Pharmaceutical & Biotechnology Companies
• 8.4. Academics & Research Institutes
• 8.5. Other End Users

9. Global NGS Services Market, by Geography

• 9.1. Introduction
• 9.2. North America
  • 9.2.1. U.S.
  • 9.2.2. Canada
• 9.3. Europe
  • 9.3.1. Germany
  • 9.3.2. France
  • 9.3.3. U.K.
  • 9.3.4. Italy
  • 9.3.5. Spain
  • 9.3.6. Rest of Europe (RoE)
• 9.4. Asia-Pacific
  • 9.4.1. Japan
  • 9.4.2. China
  • 9.4.3. India
  • 9.4.4. Rest of Asia-Pacific (RoAPAC)
• 9.5. Latin America
• 9.6. Middle East & Africa

10. Competitive Landscape

• 10.1. Introduction
• 10.2. Key Growth Strategies
• 10.3. Competitive Benchmarking
• 10.4. Market Share Analysis (2020)
  • 10.4.1. Eurofins Scientific S.E.
  • 10.4.2. Illumina, Inc.
  • 10.4.3. Perkinelmer, Inc.
  • 10.4.4. GENEWIZ, Inc.
  • 10.4.5. Foundation Medicine, Inc. (Subsidiary of F. Hoffmann-La Roche AG)

11. Company Profiles

• 11.1. Illumina, Inc.
  • 11.1.1. Business Overview
  • 11.1.2. Financial Overview
  • 11.1.3. Service Portfolio
  • 11.1.4. Strategic Developments
• 11.2. QIAGEN N.V.
  • 11.2.1. Business Overview
  • 11.2.2. Financial Overview
  • 11.2.3. Service Portfolio
• 11.3. PerkinElmer, Inc.
  • 11.3.1. Business Overview
  • 11.3.2. Financial Overview
  • 11.3.3. Service Portfolio
• 11.4. Eurofins Scientific S.E.
  • 11.4.1. Business Overview
  • 11.4.2. Financial Overview
  • 11.4.3. Service Portfolio
  • 11.4.4. Strategic Developments
• 11.5. Macrogen, Inc.
  • 11.5.1. Company Overview
  • 11.5.2. Financial Overview
  • 11.5.3. Service Portfolio
  • 11.5.4. Strategic Developments
• 11.6. LGC Limited
  • 11.6.1. Business Overview
  • 11.6.2. Financial Overview
  • 11.6.3. Service Portfolio
  • 11.6.4. Strategic Developments
• 11.7. GENEWIZ, Inc.
  • 11.7.1. Business Overview
  • 11.7.2. Financial Overview
  • 11.7.3. Service Portfolio
  • 11.7.4. Strategic Developments
• 11.8. Beijing Genomics Institute (BGI)
  • 11.8.1. Business Overview
  • 11.8.2. Service Portfolio
  • 11.8.3. Strategic Developments
• 11.9. Scigenom Labs Pvt., Ltd.
  • 11.9.1. Business Overview
  • 11.9.2. Service Portfolio
• 11.10. Medgenome Inc.
  • 11.10.1. Business Overview
  • 11.10.2. Service Portfolio
  • 11.10.3. Strategic Developments
• 11.11. DNA Link, Inc.
  • 11.11.1. Business Overview
  • 11.11.2. Service Portfolio
• 11.12. Otogenetics Corporation
  • 11.12.1. Business Overview
  • 11.12.2. Service Portfolio
• 11.13. Novogene Co., Ltd.
  • 11.13.1. Business Overview
  • 11.13.2. Service Portfolio
  • 11.13.3. Strategic Developments
• 11.14. CD Genomics
  • 11.14.1. Business Overview
  • 11.14.2. Service Portfolio
  • 11.14.3. Strategic Developments
• 11.15. SeqLL Inc.
  • 11.15.1. Business Overview
  • 11.15.2. Financial Overview
  • 11.15.3. Service Portfolio
• 11.16. Foundation Medicine, Inc. (Subsidiary of F. Hoffmann-La Roche AG)
  • 11.16.1. Business Overview
  • 11.16.2. Financial Overview
  • 11.16.3. Service Portfolio
  • 11.16.4. Strategic Developments

12. Appendix

• 12.1. Questionnaire
• 12.2. Available Customization